OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review
Donald C. Moore, Joseph B. Elmes, Justin Arnall, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111606-111606
Closed Access | Times Cited: 14
Donald C. Moore, Joseph B. Elmes, Justin Arnall, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111606-111606
Closed Access | Times Cited: 14
Showing 14 citing articles:
Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
Ruichen Gao, Wenjun Liang, Jintao Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Ruichen Gao, Wenjun Liang, Jintao Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting system database
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
G. Liu, Shuxian Zhang, Zhuang Mo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study
Zhouwei Zhan, Bijuan Chen, Shaohua Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zhouwei Zhan, Bijuan Chen, Shaohua Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Pembrolizumab associated immune thrombocytopenia
Perihan Perkin, Serhat Sekmek, Doğan Bayram, et al.
Journal of Chemotherapy (2025), pp. 1-5
Closed Access
Perihan Perkin, Serhat Sekmek, Doğan Bayram, et al.
Journal of Chemotherapy (2025), pp. 1-5
Closed Access
Hepatoblastoma: From Molecular Mechanisms to Therapeutic Strategies
Fan Ling, Jintong Na, Tieliu Shi, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 149-149
Open Access
Fan Ling, Jintong Na, Tieliu Shi, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 149-149
Open Access
Immune-induced thrombocytopenia by pembrolizumab: case report and review of literature
Nathan El-Ghazzi, Anna Monier, A. Italiano, et al.
Platelets (2025) Vol. 36, Iss. 1
Open Access
Nathan El-Ghazzi, Anna Monier, A. Italiano, et al.
Platelets (2025) Vol. 36, Iss. 1
Open Access
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database
Huiping Zhang, Zhuo Zhou, Juan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Huiping Zhang, Zhuo Zhou, Juan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report
Shadi Chamseddine, Michael LaPelusa, Kristen Carter, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 1324-1330
Open Access | Times Cited: 1
Shadi Chamseddine, Michael LaPelusa, Kristen Carter, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 1324-1330
Open Access | Times Cited: 1
Thrombocytopenia and hyperprogression after radiotherapy and camrelizumab treatment in an esophageal cancer patient with increased JAK2 gene copies: a case report
Hang Wang, Yun Li, Min Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Hang Wang, Yun Li, Min Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Drug-induced thrombocytopenia
Nada Suvajdžić, Mirjana Cvetković
Srpski medicinski casopis Lekarske komore (2024) Vol. 5, Iss. 3, pp. 382-392
Open Access | Times Cited: 1
Nada Suvajdžić, Mirjana Cvetković
Srpski medicinski casopis Lekarske komore (2024) Vol. 5, Iss. 3, pp. 382-392
Open Access | Times Cited: 1
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Diwei Mo, Xia Yang, Guifeng Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Diwei Mo, Xia Yang, Guifeng Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Immune thrombocytopenia (ITP) - could it be part of autoimmune/inflammatory syndrome induced by adjuvants (ASIA)?
Paula David, Gabrielle de Mello Santos, Yonatan Shneor Patt, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 9, pp. 103605-103605
Closed Access
Paula David, Gabrielle de Mello Santos, Yonatan Shneor Patt, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 9, pp. 103605-103605
Closed Access
Can tissue-specific PD-1/PD-L1 targeting combined with other immune checkpoint blockades enhance immune clearance?
Sadia Ahmad, Amna Rehman, Ali Afzal, et al.
Medical Hypotheses (2024), pp. 111491-111491
Closed Access
Sadia Ahmad, Amna Rehman, Ali Afzal, et al.
Medical Hypotheses (2024), pp. 111491-111491
Closed Access
